Cart
sales@molnova.com
Olaquindox
CAS No. 23696-28-8
Olaquindox( Bayernox | Bayonox | Bisergon | Olachindox | Olaquindoxum | Olaquindox )
Catalog No. M13684 CAS No. 23696-28-8
Olaquindox is a growth stimulant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 38 | In Stock |
|
| 100MG | 55 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 132 | In Stock |
|
| 1G | 184 | In Stock |
|
Biological Information
-
Product NameOlaquindox
-
NoteResearch use only, not for human use.
-
Brief DescriptionOlaquindox is a growth stimulant.
-
DescriptionOlaquindox is a growth stimulant.
-
In Vitro——
-
In VivoOlaquindox (100 mg/kg in the basal diet) improves average daily gain and feed conversion ratio (FCR).
-
SynonymsBayernox | Bayonox | Bisergon | Olachindox | Olaquindoxum | Olaquindox
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number23696-28-8
-
Formula Weight263.2
-
Molecular FormulaC12H13N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C(C1=C(C)[N+]([O-])=C2C=CC=CC2=[N+]1[O-])NCCO
-
Chemical Name2-((2-hydroxyethyl)carbamoyl)-3-methylquinoxaline 1,4-dioxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Le T, Zhu L, Yu H. Dual-label quantum dot-based immunoassay for simultaneous determination of Carbadox and Olaquindox metabolites in animal tissues. Food Chem. 2016 May 15;199:70-4. doi: 10.1016/j.foodchem.2015.11.116. Epub 2015 Nov 26. PubMed PMID: 26775945.
molnova catalog
related products
-
6-Thio-dG
6-thio-dG is a nucleoside analog and telomerase substrate.
-
Ebopiprant
Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.
-
Bavituximab
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a monoclonal antibody targeting phosphatidylserine (PS) with vascular targeting and immunomodulatory properties, capable of reactivating anti-tumor immunity to inhibit tumor growth.
